Today: 21 April 2026
Subscribe
Browse Category

NASDAQ:FORD 23 September 2025 - 17 October 2025

Solana’s $195 Lifeline: Can Bulls Turn This Dip Into a $250+ Comeback Rally?

Solana’s $195 Lifeline: Can Bulls Turn This Dip Into a $250+ Comeback Rally?

Solana’s price has dropped to around $186–$195 after peaking above $250 in early October, testing a key support zone. Nearly $400 million in SOL left exchanges in recent days, signaling heavy profit-taking and reduced liquidity. Andreessen Horowitz invested $50 million in a Solana staking firm, while Forward Industries raised $1.65 billion to buy SOL. Analysts see $186–$195 as critical; failure to hold could send SOL toward $172 or lower.
17 October 2025
·
Applied Digital (APLD) Skyrockets on AI Deals – Is the Rally Sustainable?

Forward Industries’ 500% Surge: Inside the $4B Solana Bet Transforming a Tiny Stock

Forward Industries closed at $25.43 on Oct. 6, 2025, up over 400% year-to-date after pivoting to become a Solana treasury. The company raised $1.65 billion, bought 6.82 million SOL, and staked all tokens on-chain. On Oct. 7, Forward launched a top-10 Solana validator node with DoubleZero. Legacy financials remain weak, with analysts downgrading the stock despite the surge.
7 October 2025
··
Applied Digital (APLD) Skyrockets on AI Deals – Is the Rally Sustainable?

Forward Industries’ Wild Crypto Pivot: $4B Solana Bet, 500% Stock Surge & Wall Street Skepticism

Forward Industries closed at $25.43 on October 6, 2025, up over 400% year-to-date after pivoting from carrying cases to a Solana crypto treasury. The company raised $1.65 billion, bought 6.82 million SOL, and filed for a $4 billion stock offering. Shares hit $46 in September before dropping. Analysts have downgraded the stock, citing poor fundamentals and a recent net loss.
7 October 2025
··
Solana’s Meteoric 2025 Surge: Uptober Rally, ‘New Wall Street’ Hype & Bold Forecasts

Solana’s Meteoric 2025 Surge: Uptober Rally, ‘New Wall Street’ Hype & Bold Forecasts

Solana’s SOL token surged 9% in early October 2025 to $227, its highest since January, after a volatile September. Multiple spot Solana ETF applications face SEC review this month, with the first decision expected October 10. Solana’s DeFi TVL topped $30 billion, and major firms like Galaxy Digital and VisionSys AI announced billion-dollar SOL allocations. The Alpenglow upgrade is set to cut transaction finality to 0.15 seconds.
5 October 2025
··
Applied Digital (APLD) Skyrockets on AI Deals – Is the Rally Sustainable?

Forward Industries (FORD) Shocks Wall Street with 2025 Crypto Pivot – 500% Stock Surge & $4B Solana Bet Revealed

Forward Industries’ shares surged over 500% in 2025 after the company shifted from manufacturing to become a major Solana holder, acquiring 6.8 million SOL tokens for $1.58 billion. The firm raised $1.65 billion from crypto investors and filed for a $4 billion at-the-market stock offering. Forward also announced plans to tokenize its shares on Solana. Legacy revenues remain low, with a $2.17 per-share loss last quarter.
23 September 2025
··

Stock Market Today

  • Sensex surges 753 points as US-Iran peace talks boost Indian markets
    April 21, 2026, 11:33 AM EDT. The Sensex jumped 753 points to 79,273.33 and the Nifty 50 crossed 24,550 amid growing optimism over US-Iran peace talks, easing crude oil prices, and strong earnings from key sectors. The market capitalization of BSE-listed companies rose by ₹3 lakh crore in one day, reaching nearly ₹469 lakh crore. Banking and FMCG stocks led the gains, with Nestle India, Hindustan Unilever, and Trent as top gainers. Sectoral indices like Nifty Bank and FMCG surged, while Pharma and Consumer Durables slipped slightly. Analysts said easing geopolitical tensions and falling crude prices lifted risk appetite, despite mid and small-cap segments underperforming. Investors remain focused on corporate earnings and global developments.

Latest article

Eli Lilly to Buy Kelonia for Up to $7 Billion as In Vivo CAR-T Gains Ground

Eli Lilly to Buy Kelonia for Up to $7 Billion as In Vivo CAR-T Gains Ground

21 April 2026
Eli Lilly will acquire Boston-based Kelonia Therapeutics for up to $7 billion in cash, including $3.25 billion upfront, to expand into in vivo CAR-T cancer therapies. Kelonia’s KLN-1010, in Phase 1 for multiple myeloma, generates engineered T-cells inside the patient. The deal marks Lilly’s third Massachusetts biotech purchase in 2026. Kelonia had 62 employees and nearly ran out of cash before the offer.
POET Technologies Stock Soars Again as PFIC Tax Clarity Eases Short-Seller Fears

POET Technologies Stock Soars Again as PFIC Tax Clarity Eases Short-Seller Fears

21 April 2026
POET Technologies shares surged 20% Tuesday, following an 18% gain Monday, after the company addressed U.S. shareholder tax concerns and announced plans to redomicile. Nearly 32.9 million shares traded by 10:21 a.m. ET, with the stock reaching $11.07 before settling at $10.34. Wolfpack Research disclosed a short position last week, sparking volatility. CFO Thomas Mika said POET expects not to qualify as a PFIC in 2026.
Why Rocket Lab Stock Is Rising Again as Analysts Lift Targets and Golden Dome Spending Comes Into Focus

Why Rocket Lab Stock Is Rising Again as Analysts Lift Targets and Golden Dome Spending Comes Into Focus

21 April 2026
Rocket Lab shares rose 2% to $91.12 Tuesday after analysts raised price targets and the Pentagon detailed new space defense spending in its 2027 budget request. The company closed its $155 million Mynaric acquisition last week and reported a $190 million Pentagon launch contract in March, bringing its backlog above $2 billion. Rocket Lab now expects to launch its Neutron rocket in late 2026 after a test setback.
Go toTop